Effect of Second-generation vs Third-generation Chemotherapy Regimens With Thoracic Radiotherapy on Unresectable Stage III Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Effect of Second-generation vs Third-generation Chemotherapy Regimens With Thoracic Radiotherapy on Unresectable Stage III Non–Small-Cell Lung Cancer

Published:2021-06-01 Issue:6 Volume:7 Page:904
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Zenke Yoshitaka¹,Tsuboi Masahiro²,Chiba Yasutaka³,Tsujino Kayoko⁴,Satouchi Miyako⁵,Sawa Kenji⁶,Shimizu Junichi⁷,Daga Haruko⁸,Fujimoto Daichi⁹,Mori Masahide¹⁰,Aoki Takuya¹¹,Sawa Toshiyuki¹²,Omori Shota¹³,Saka Hideo¹⁴,Iwamoto Yasuo¹⁵,Okuno Motoyasu¹⁶,Hirashima Tomonori¹⁷,Kashiwabara Kosuke¹⁸,Tachihara Motoko¹⁹,Ymamoto Nobuyuki²⁰,Nakagawa Kazuhiko²¹

Affiliation:

1. Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan

2. Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan

3. Clinical Research Center, Kindai University Hospital, Osaka, Japan

4. Department of Radiation Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan

5. Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan

6. Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan

7. Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan

8. Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan

9. Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

10. Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan

11. Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan

12. Division of Respiratory Medicine and Oncology, Gifu Municipal Hospital, Gifu, Japan

13. Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

14. Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan

15. Department of Respiratory Medicine, Hiroshima City Hospital, Hiroshima, Japan

16. Department of Respiratory Medicine, Okazaki City Hospital, Okazaki, Japan

17. Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, Osaka, Japan

18. Department of Respiratory Medicine, Kumamoto Regional Medical Center, Kumamoto, Japan

19. Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

20. Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan

21. Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2777344/jamaoncology_zenke_2021_br_210003_1623352063.18455.pdf

Reference12 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer.;Aupérin;J Clin Oncol,2010

2. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.;Curran;J Natl Cancer Inst,2011

3. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non–small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.;Yamamoto;J Clin Oncol,2010

4. Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: a retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A).;Ohe;Cancer Sci,2003

5. Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.;Horinouchi;Cancer Sci,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivorship Program Including Long-Term Toxicities and Quality-of-Life Development Over Ten Years within a Randomized Phase-III Trial in Operable Stage III Non-Small-Cell Lung Cancer (ESPATUE);2023-12-11

2. Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non–Small Cell Lung Cancer;JAMA Oncology;2023-11-01

3. Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles;Thoracic Cancer;2023-08-24

4. Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society;Haigan;2023-06-20

5. Identification of a transcription factor‑cyclin family genes network in lung adenocarcinoma through bioinformatics analysis and validation through RT‑qPCR;Experimental and Therapeutic Medicine;2022-12-09